Direct Regulation of RNA Polymerase III Transcription by RB, p53 and c-Myc

The synthesis of tRNA and 5S rRNA by RNA polymerase (pol) III is cell cycle regulated in higher organisms. Overexpression of pol III products is a general feature of transformed cells. These observations may be explained by the fact that a pol III-specific transcription factor, TFIIIB, is strongly regulated by the tumour suppressors RB and p53, as well as the proto-oncogene product c-Myc. RB and p53 repress TFIIIB, but this restraint can be lost in tumours through a variety of mechanisms. In contrast, c-Myc binds and activates TFIIIB, causing potent induction of pol III transcription. Using chromatin immunoprecipitation and RNA interference, we show that c-Myc interacts with tRNA and 5S rRNA genes in transformed cervical cells, stimulating their expression. Availability of pol III products may be an important determinant of a cell's capacity to grow. The ability to regulate pol III output may therefore be integral to the growth control functions of RB, p53 and c-Myc.

[1]  R. Eisenman,et al.  Direct activation of RNA polymerase III transcription by c-Myc , 2003, Nature.

[2]  Robert J. White,et al.  Multiple Mechanisms Contribute to the Activation of RNA Polymerase III Transcription in Cells Transformed by Papovaviruses* , 2002, The Journal of Biological Chemistry.

[3]  Ruedi Aebersold,et al.  Quantitative proteomic analysis of Myc oncoprotein function , 2002, The EMBO journal.

[4]  T. Stein,et al.  Several regions of p53 are involved in repression of RNA polymerase III transcription , 2002, Oncogene.

[5]  J. Varley,et al.  RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome , 2002, Oncogene.

[6]  M Schwab,et al.  N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis , 2001, The EMBO journal.

[7]  U. Weidle,et al.  The transcriptional program of a human B cell line in response to Myc. , 2001, Nucleic acids research.

[8]  J. E. Sutcliffe,et al.  Regulation of RNA Polymerase III Transcription during Cell Cycle Entry* , 2001, The Journal of Biological Chemistry.

[9]  J. E. Sutcliffe,et al.  Retinoblastoma Protein Disrupts Interactions Required for RNA Polymerase III Transcription , 2000, Molecular and Cellular Biology.

[10]  D. Spandidos,et al.  RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Ansorge,et al.  Induction of cyclin E–cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events , 2000, The EMBO journal.

[12]  C. Dang,et al.  Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Gallie,et al.  Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. , 2000, Seminars in cancer biology.

[14]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. White,et al.  Survey and summary: transcription by RNA polymerases I and III. , 2000, Nucleic acids research.

[16]  S. Elledge,et al.  Cancer: p53 sends nucleotides to repair DNA , 2000, Nature.

[17]  T. Stein,et al.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents. , 2000, Gene expression.

[18]  R. Eisenman,et al.  c-Myc enhances protein synthesis and cell size during B lymphocyte development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[20]  D. Prober,et al.  Drosophila myc Regulates Cellular Growth during Development , 1999, Cell.

[21]  J. E. Sutcliffe,et al.  Activation of RNA Polymerase III Transcription in Cells Transformed by Simian Virus 40 , 1999, Molecular and Cellular Biology.

[22]  J. E. Sutcliffe,et al.  RNA Polymerase III Transcription Factor IIIB Is a Target for Repression by Pocket Proteins p107 and p130 , 1999, Molecular and Cellular Biology.

[23]  Emmett V Schmidt,et al.  The role of c-myc in cellular growth control , 1999, Oncogene.

[24]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[25]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[26]  J. Niland,et al.  The MDM2 gene amplification database. , 1998, Nucleic acids research.

[27]  Robert J White,et al.  p53 is a general repressor of RNA polymerase III transcription , 1998, The EMBO journal.

[28]  R. White.  Transcription factor IIIB: An important determinant of biosynthetic capacity that is targeted by tumour suppressors and transforming proteins. , 1998, International journal of oncology.

[29]  W. Sellers,et al.  Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. , 1998, Genes & development.

[30]  Robert J White.  RNA Polymerase III Transcription , 1998, Biotechnology Intelligence Unit.

[31]  D. Johnson,et al.  Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway , 1997, Molecular and cellular biology.

[32]  J. Brosius,et al.  Expression of neural BC200 RNA in human tumours , 1997, The Journal of pathology.

[33]  J. Sedivy,et al.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  C. Schmid,et al.  RNA Polymerase III Transcription Repressed by Rb through Its Interactions with TFIIIB and TFIIIC2* , 1997, The Journal of Biological Chemistry.

[35]  S. Jackson,et al.  Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein , 1997, The EMBO journal.

[36]  J. Brosius,et al.  Expression of neural BC1 RNA: induction in murine tumours. , 1997, European journal of cancer.

[37]  Y Luo,et al.  C‐myc deregulation during transformation induction: involvement of 7SK RNA , 1997, Journal of cellular biochemistry.

[38]  D. Evans,et al.  Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.

[39]  C. Schmid,et al.  p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner , 1996, Molecular and cellular biology.

[40]  S. Jackson,et al.  Repression of RNA polymerase III transcription by the retinoblastoma protein , 1996, Nature.

[41]  I. Rosenwald,et al.  Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells. , 1996, Cancer letters.

[42]  J. Nyborg,et al.  Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein. , 1996, Molecular and cellular biology.

[43]  C. Yuh,et al.  The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes , 1995, Molecular and cellular biology.

[44]  S. Jackson,et al.  Cell cycle regulation of RNA polymerase III transcription , 1995, Molecular and cellular biology.

[45]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[46]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[47]  K. Vousden.  Regulation of the cell cycle by viral oncoproteins. , 1995, Seminars in cancer biology.

[48]  G. Peters,et al.  Cyclin D1 as a cellular proto-oncogene. , 1995, Seminars in cancer biology.

[49]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[50]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[51]  F. Kaye,et al.  Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. , 1994, Oncogene.

[52]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[53]  P. Rigby,et al.  Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. , 1990, The EMBO journal.

[54]  N. Dyson,et al.  The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.

[55]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[56]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[57]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[58]  P. Rigby,et al.  Activation of mouse genes in transformed cells , 1983, Cell.